PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 23, 2021– PerkinElmer, Inc. (NYSE: PKI) today announced the launch of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens. The lateral flow... Read more

Danaher To Present At Cowen Healthcare Conference

WASHINGTON, Feb. 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Cowen Healthcare Conference on Monday, March 1, 2021 at 11:40 a.m. ET. The video will be simultaneously webcast on www.danaher.com.  ABOUT DANAHERDanaher is a global science and technology innovator committed... Read more

PerkinElmer Provides an Update on Valencia Branch Laboratory’s Accreditation Process

WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 22, 2021– PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today provided an update on the COVID-19 Valencia Branch Laboratory’s (VBL) accreditation process. The VBL is operated by PerkinElmer in partnership with the California Department of Public Health (CDPH). The VBL started operations on November 1,... Read more

Bruker Corporation to Present at Investor Conferences

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences: 10th Annual SVB Leerink Healthcare Conference Thursday, February 25, 2021, at 8:40 a.m. Eastern TimeFrank Laukien, Chairman, President and Chief Executive Officer Cowen 41st Annual Health Care Conference Tuesday, March 2, 2021, at 11:10 a.m. Eastern TimeGerald Herman,... Read more

QIAGEN announces Digital Partner Program with five initial partnerships

Redwood City, California, and Hilden, Germany, February 18, 2021 – QIAGEN today announced the launch of the QIAGEN Digital Insights Partnership program for genomic vendors to leverage QIAGEN’s genomic content and analysis leadership to expand customer access and deliver extended genomic solutions for scientists and clinicians. The first group of five new partnerships involves DNAnexus,... Read more

Thermo Fisher Scientific Recognized with Six CMO Leadership Awards

WALTHAM, Mass., Feb. 18, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by Life Science Leader and Outsourced Pharma, recognize top contract manufacturing partners as evaluated by biopharma and biotech companies. Thermo Fisher won across... Read more

Easy-to-Use Reversed-Phase Capillary Columns and Emitters Improve High-Resolution LC-MS Analysis

Easy-to-Use Reversed-Phase Capillary Columns and Emitters Improve High-Resolution LC-MS Analysis The Thermo Scientific MAbPac Reversed-Phase Capillary HPLC Columns and Emitters achieve sensitive, reproducible and robust high throughput analysis with minimal sample volume VILNIUS, Lithuania, Feb. 18, 2021 /PRNewswire/ — Proteomics, clinical peptides and biopharmaceutical research laboratories performing high throughput, high-performance liquid chromatography (HPLC), or liquid chromatography-mass... Read more

Bruker Announces Quarterly Dividend

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock. The dividend will be paid on March 19, 2021 to stockholders of record as of March 5, 2021. About Bruker Corporation... Read more

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs

Thermo Fisher Scientific Acquires Leading Cell Sorting Technology from Propel Labs WALTHAM, Mass., Feb. 17, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced it has acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp. Under the terms of the agreement, the recently... Read more